Index - P/E - EPS (ttm) -5.37 Insider Own 52.08% Shs Outstand 7.95M Perf Week 3.49%
Market Cap 63.65M Forward P/E - EPS next Y -2.40 Insider Trans 201.90% Shs Float 3.81M Perf Month 15.11%
Enterprise Value 119.88M PEG - EPS next Q -0.94 Inst Own 17.84% Short Float 4.94% Perf Quarter -5.88%
Income -39.54M P/S 0.79 EPS this Y 21.39% Inst Trans -22.11% Short Ratio 0.85 Perf Half Y 32.80%
Sales 80.17M P/B - EPS next Y 53.71% ROA -41.30% Short Interest 0.19M Perf YTD -73.86%
Book/sh -0.22 P/C 3.81 EPS next 5Y 41.47% ROE -302.55% 52W High 32.20 -75.16% Perf Year -71.43%
Cash/sh 2.10 P/FCF - EPS past 3/5Y 40.57% 69.26% ROIC -56.64% 52W Low 3.44 132.83% Perf 3Y -60.78%
Dividend Est. - EV/EBITDA - Sales past 3/5Y 9.38% 23.77% Gross Margin 79.82% Volatility 8.66% 11.65% Perf 5Y -96.33%
Dividend TTM - EV/Sales 1.50 EPS Y/Y TTM 31.93% Oper. Margin -40.35% ATR (14) 0.78 Perf 10Y -
Dividend Ex-Date - Quick Ratio 1.76 Sales Y/Y TTM 22.29% Profit Margin -49.31% RSI (14) 55.48 Recom 1.40
Dividend Gr. 3/5Y - - Current Ratio 1.84 EPS Q/Q 17.13% SMA20 11.47% Beta 0.59 Target Price 32.50
Payout - Debt/Eq - Sales Q/Q 19.93% SMA50 7.13% Rel Volume 0.37 Prev Close 7.90
Employees 273 LT Debt/Eq - Earnings Nov 03 AMC SMA200 -17.23% Avg Volume 221.65K Price 8.00
IPO Oct 28, 2020 Option/Short No / Yes EPS/Sales Surpr. 22.15% 3.79% Trades
Volume 81,025 Change 1.27%
Date
Action
Analyst
Rating Change
Price Target Change
May-14-25 Downgrade William Blair
Outperform → Mkt Perform
Sep-16-24 Initiated Scotiabank
Sector Outperform
Jul-26-24 Initiated Craig Hallum
Buy
$3
May-13-24 Initiated TD Cowen
Buy
$2.80
May-03-24 Initiated Lake Street
Buy
$3
Nov-17-21 Downgrade Morgan Stanley
Overweight → Equal-Weight
$21 → $11
Nov-23-20 Initiated William Blair
Outperform
Nov-23-20 Initiated Morgan Stanley
Overweight
$20
Nov-23-20 Initiated Canaccord Genuity
Buy
$26
Nov-23-20 Initiated BTIG Research
Buy
$22
Nov-04-25 12:01AM
Nov-03-25 05:30PM
04:01PM
Oct-31-25 09:35AM
Oct-30-25 06:17AM
05:45PM
Loading…
Oct-29-25 05:45PM
Oct-27-25 07:10AM
Oct-22-25 06:17AM
Oct-20-25 06:00AM
Oct-15-25 06:09AM
Oct-06-25 10:13AM
Sep-11-25 08:00AM
Sep-05-25 06:00AM
Sep-04-25 10:30AM
(Associated Press Finance) +5.05%
Aug-19-25 09:47AM
05:20PM
Loading…
Aug-07-25 05:20PM
04:06PM
Aug-05-25 06:00AM
Aug-01-25 07:15AM
Jul-25-25 12:22PM
12:22PM
Jul-24-25 06:00AM
Jun-10-25 06:17AM
May-22-25 05:03PM
May-21-25 06:00AM
May-15-25 06:00AM
May-14-25 04:01PM
03:16AM
May-13-25 05:15PM
04:01PM
09:50AM
Loading…
May-12-25 09:50AM
09:25AM
May-08-25 06:30PM
Apr-30-25 07:45AM
Apr-29-25 06:00AM
Apr-28-25 07:15AM
Apr-25-25 07:15AM
Apr-23-25 06:00AM
Mar-06-25 12:00PM
Mar-04-25 05:20AM
02:03AM
Mar-03-25 04:01PM
Feb-28-25 07:15AM
Feb-26-25 06:00AM
Feb-18-25 06:00AM
Jan-10-25 06:00AM
Jan-07-25 06:00AM
Nov-20-24 09:35AM
Nov-02-24 03:01AM
Nov-01-24 07:15AM
06:00AM
Oct-31-24 09:06AM
Oct-29-24 06:00AM
Oct-18-24 06:00AM
Oct-07-24 06:00AM
Sep-05-24 06:00AM
Aug-08-24 10:23AM
(Thomson Reuters StreetEvents)
Aug-07-24 06:05PM
04:01PM
Aug-06-24 06:00AM
Jul-24-24 06:00AM
Jun-18-24 08:13AM
May-28-24 06:00AM
May-21-24 06:00AM
May-10-24 05:59PM
03:55PM
May-09-24 03:46AM
May-08-24 09:00PM
05:20PM
04:01PM
May-07-24 06:00AM
Apr-24-24 06:00AM
Apr-09-24 05:00PM
Apr-05-24 07:17AM
Mar-25-24 06:00AM
Mar-04-24 09:04AM
Mar-01-24 10:40PM
(Thomson Reuters StreetEvents)
06:31AM
06:00AM
Feb-26-24 06:00AM
Feb-16-24 06:00AM
Feb-13-24 03:00AM
Jan-26-24 09:04AM
Nov-14-23 06:00AM
Nov-09-23 06:00AM
Nov-07-23 04:01PM
Oct-24-23 06:00AM
Oct-03-23 06:00AM
Sep-07-23 06:00AM
Sep-05-23 06:00AM
Aug-22-23 06:00AM
Aug-09-23 10:25AM
Aug-08-23 08:38AM
(Thomson Reuters StreetEvents)
Aug-07-23 05:15PM
04:01PM
Aug-01-23 06:00AM
Jul-26-23 07:58AM
Jul-24-23 06:00AM
Jul-12-23 06:00AM
Jul-06-23 09:11AM
Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Vazquez Chris Chief Accounting Officer Nov 10 '25 Sale 7.62 13 99 936 Nov 13 04:54 PM Pestano Gary Anthony Chief Development Officer Nov 10 '25 Sale 7.62 23 175 7,939 Nov 13 04:54 PM O'Kane Kieran Chief Commercial Officer Nov 10 '25 Sale 7.62 25 190 7,362 Nov 13 04:53 PM Hutton Scott President & CEO Nov 10 '25 Sale 7.62 189 1,440 37,311 Nov 13 04:53 PM Cowie Robin Harper CFO, Sec'y & Treasurer Nov 10 '25 Sale 7.62 50 381 13,147 Nov 13 04:53 PM SCHULER JACK W Director Sep 19 '25 Buy 7.04 142,045 999,997 1,380,745 Sep 23 09:29 AM SCHULER JACK W Director Sep 17 '25 Buy 6.04 15,317 92,571 1,235,644 Sep 19 10:31 AM SCHULER JACK W Director Sep 18 '25 Buy 6.17 3,056 18,854 1,238,700 Sep 19 10:31 AM SCHULER JACK W Director Aug 29 '25 Buy 0.43 3,488,372 1,500,000 24,406,546 Sep 03 04:42 PM Cowie Robin Harper CFO, Sec'y & Treasurer Aug 13 '25 Sale 0.42 988 411 250,794 Aug 14 05:25 PM Hutton Scott President & CEO Aug 13 '25 Sale 0.42 3,772 1,570 728,824 Aug 14 05:25 PM O'Kane Kieran Chief Commercial Officer Aug 13 '25 Sale 0.42 476 198 140,065 Aug 14 05:24 PM Pestano Gary Anthony Chief Development Officer Aug 13 '25 Sale 0.42 442 184 157,878 Aug 14 05:24 PM Vazquez Chris Chief Accounting Officer Aug 13 '25 Sale 0.42 228 95 18,375 Aug 14 05:24 PM SCHULER JACK W Director May 16 '25 Buy 0.27 4,000,000 1,070,000 20,194,935 May 20 04:11 PM SCHULER JACK W Director May 19 '25 Buy 0.34 723,239 246,624 20,918,174 May 20 04:11 PM Vazquez Chris Chief Accounting Officer May 12 '25 Sale 0.36 112 40 18,113 May 13 06:36 PM Vazquez Chris Chief Accounting Officer May 13 '25 Sale 0.35 112 40 18,001 May 13 06:36 PM Pestano Gary Anthony Chief Development Officer May 12 '25 Sale 0.36 223 80 157,163 May 13 06:36 PM Pestano Gary Anthony Chief Development Officer May 13 '25 Sale 0.35 222 78 156,941 May 13 06:36 PM O'Kane Kieran Chief Commercial Officer May 12 '25 Sale 0.36 239 86 139,290 May 13 06:35 PM O'Kane Kieran Chief Commercial Officer May 13 '25 Sale 0.35 238 84 139,052 May 13 06:35 PM Hutton Scott President & CEO May 12 '25 Sale 0.36 1,888 679 722,271 May 13 06:35 PM Hutton Scott President & CEO May 13 '25 Sale 0.35 1,887 666 720,384 May 13 06:35 PM Cowie Robin Harper CFO, Sec'y & Treasurer May 12 '25 Sale 0.36 496 178 249,121 May 13 06:35 PM Cowie Robin Harper CFO, Sec'y & Treasurer May 13 '25 Sale 0.35 496 175 248,625 May 13 06:35 PM Vazquez Chris Chief Accounting Officer Feb 11 '25 Sale 0.92 3,630 3,355 17,623 Feb 12 05:12 PM Pestano Gary Anthony Chief Development Officer Feb 11 '25 Sale 0.92 16,748 15,479 156,008 Feb 12 05:12 PM O'Kane Kieran Chief Commercial Officer Feb 11 '25 Sale 0.92 17,527 16,198 128,039 Feb 12 05:11 PM Hutton Scott President & CEO Feb 11 '25 Sale 0.92 83,660 77,319 701,947 Feb 12 05:11 PM Cowie Robin Harper CFO, Sec'y & Treasurer Feb 11 '25 Sale 0.92 24,664 22,794 246,460 Feb 12 05:11 PM Hutton Scott Officer Feb 11 '25 Proposed Sale 0.95 83,660 79,477 Feb 11 04:41 PM Cowie Robin Harper Officer Feb 11 '25 Proposed Sale 0.95 24,664 23,431 Feb 11 04:41 PM Pestano Gary Anthony Officer Feb 11 '25 Proposed Sale 0.95 16,748 15,911 Feb 11 04:41 PM O'Kane Kieran Officer Feb 11 '25 Proposed Sale 0.95 17,527 16,651 Feb 11 04:40 PM SCHULER JACK W Director Nov 21 '24 Buy 1.23 100,000 122,840 31,194,935 Nov 22 12:30 PM Kennedy Lawrence T. Jr Director Nov 21 '24 Buy 1.16 35,000 40,562 10,411,024 Nov 22 12:30 PM SCHULER JACK W Director Nov 20 '24 Buy 1.17 200,000 234,000 31,094,935 Nov 21 03:30 PM
